5401452026-05-195401452026-05-192026-05-195401452026-05-192026-05-19UnitOrDivisionOrSubsidiaryDomain15401452026-05-19UnitOrDivisionOrSubsidiaryDomain1iso4217:INRxbrli:pure540145Valiant Organics LimitedVALIANTORGNOTLISTEDINE565V01010NewSale or disposal of unit(s)/division(s)/subsidiarytrue2026-05-1920:10:002026-05-19SubsidiaryDhanvallabh Ventures LLP38000000.000538000000.000538000000.00058379000000.11342026-05-192026-05-19SharesIn consideration of the Company’s cessation as a partner of DVLLP and disposal of its shares of Valiant Laboratories Limited, in the manner and on the terms set out in the definitive documents. partnership interest therein, the Settlement Amount attributable to the Company is proposed to be discharged by transfer by DVLLP to the Company of 1,86,07,531 equity shares of Valiant Laboratories Limited, in the manner and on the terms set out in the definitive documents.The counterparty to the proposed transaction is DVLLP. DVLLP is a related party of the Company being a subsidiarytrueMembers of the Promoter / Promoter Group of the Company are holding more than 20% of the partnership interest in the LLP.true2026-05-192026-05-19true2026-05-19truefalseThe proposed transaction is subject to the approval of the shareholders of the Company and other requisite approvals, which are yet to be received by the Company. Accordingly, we are presently unable to provide a definitive timeline for completion of the transaction.Further, we request you to kindly refer to our PDF announcement. Solely for the purpose of resolving XBRL validation errors, the date of the Board Meeting has been mentioned under the tabs titled Date on which agreement for sale has been entered into, Expected date of completion of sale and Date of approval from shareholders, wherever required.